Wyomissing Optometric Center is the first optometric practice in Berks County to implement the AdaptDxPRO®, a new portable technology to aid in the early diagnosis of age-related macular degeneration (AMD). AMD is the leading cause of adult blindness in developed countries.  Early diagnosis is key to slowing down the progression of the disease process. MacuLogix introduced the original AdaptDx® in 2014 as the first fully-automated dark adaptometer for clinical use. Since then, hundreds of practices and thousands of eye care professionals have been using dark adaptation to diagnose and monitor AMD.

 

What is dark adaptation?

 

Dark adaptation is the ability of your eyes to adjust from seeing in the light to seeing in the dark. Think of going from bright sunlight into a darkened movie theater. How long does it take your eyes to adjust? That is dark adaptation. Research shows that dark adaptation weakens at the earliest stages of AMD. This is why you might experience trouble seeing at night, reading in dim light, or adjusting to seeing in the dark. As the disease progresses, night vision difficulties increase.

 

Why AdaptDx® technology?

 

Dr. Greg Jackson, Co-founder and Chief Technology Officer for Maculogix developed the first commercially available dark adaptometer, AdaptDx®. He, along with several members of his team, visited Wyomissing Optometric Center to install Berks County’s first portable dark adaptometer, AdaptDxPRO®, on Tuesday, June 9, 2020. This device incorporates a digital camera, a retinal bleaching flash, and a Ganzfeld light source inside a pair of light-obscuring goggles. This technology offers the following advantages:

1. Ability to test patients in any available location, eliminating the need for a dedicated dark room
2. Ability to test many patients with physical disabilities who could not comfortably be tested using the desktop model
3. Ability to test more patients efficiently because of the on board tech Theia
4. Single use disposable eye cup protectors mitigates risk of transmitting germs
5. Requires less staff contact time with patients, also mitigating risk for transmission of disease

Why Wyomissing Optometric Center?

 

Wyomissing Optometric Center received the world’s first installed tabletop dark adaptometer in 2014.  Since then, Dr. Glenn Corbin President of Wyomissing Optometric Center was involved in the development of this new technology, AdaptDxPRO®.  AdaptDxPRO® is now being used at Wyomissing Optometric Center, a recognized leader in providing comprehensive vision and medical eye health care to our community.

 

Impaired Dark Adaptation: The Earliest Biomarker of Age-Related Macular Degeneration

 

Translate »